Health
Oxford/AstraZeneca vaccine 80 per cent effective against B1.617.2 variant: UK study – Yahoo India News
London, May 22 (PTI) Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the…
London, May 22 (PTI) Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly virus.
The UK findings are said to be based on…
-
Noosa News17 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General20 hours agoFirst home buyers score early access to deposit scheme
-
Noosa News18 hours agoForum responds to urgent homelessness issues in Nambour
-
General17 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers